Skip to main content

Guillemin Evan's Form 4 filing

Mesa Laboratories Inc (MLAB) · filed Aug 19, 2022

Accession no.
0001228924-22-000033
Filed
Aug 19, 2022
Trade date
Aug 18, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $724.1K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Guillemin EvanCIK 0001246295Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2022Common StockMOption exerciseAcquired+1,320$70.56+$93,139.231,108Direct
Aug 18, 2022Common StockMOption exerciseAcquired+1,000$122.66+$122,66032,108Direct
Aug 18, 2022Common StockMOption exerciseAcquired+360$142.40+$51,26432,468Direct
Aug 18, 2022Common StockSSaleDisposed−3,692$196.12−$724,075.0428,776Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 18, 2022Common StockXIn-the-money exerciseDisposed−1,320$0.00$01,450Direct
Aug 18, 2022Common StockXIn-the-money exerciseDisposed−1,000$0.00$0450Direct
Aug 18, 2022Common StockXIn-the-money exerciseDisposed−360$0.00$090Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)